EP4221704
PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES MEDIATED BY KDM1A
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
1.10.2021:
24.9.2025:
21876583.2
:
30.9.2041:
23.1.2026
:
PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES MEDIATED BY KDM1A
1.10.2021
24.9.2025
23.1.2026
:
Imago Biosciences Inc.:
2729 Debbie Court, San Carlos, CA 94070, US
:
TAPPER, Amy:
San Carlos, California 94070, US
:
CELATKA, Cassandra:
San Carlos, California 94070, US
:
SOULLIAC, Patricia:
San Carlos, California 94070, US
:
VED, Parag:
San Carlos, California 94070, US
:
VORA, Namrata:
San Carlos, California 94070, US
:
202063086353 P:
1.10.2020:
US
:
US2021053141:
1.10.2021
:
A61K 9/20, A61K 31/397, A61K 31/41, A61K 31/4162, A61P 35/02